Li C, Zhang B, Schaafsma E, Reuben A, Wang L, Turk MJ, Zhang J, Cheng C. TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs. Cell Rep Med. 2023 Jul; 4(7):101121.
Ramirez DE, Turk MJ. Th1-like Treg cells are dressed to suppress anti-tumor immunity. Immunity. 2023; 57(7):1437-1439.
Ramirez DE, Mohamed A, Huang YH, Turk MJ. In the right place at the right time: tissue-resident memory T cells in immunity to cancer. Current Opinion in Immunology. 2023; 83:102338.
Phillips JD, Fay KA, Bergeron AJ, Zhang P, Mielcarz DW, Calkins AM, Searles TG, Christensen BC, Finley DJ, Turk MJ, Channon JY. The effect of lung resection for NSCLC on circulating immune cells: a pilot study. Current Oncology. 2023; 30(5):5116-5134.
Molodtsov AK, Khatwani N, Vella JL, Lewis KA, Zhao Y, Han J, Sullivan DE, Searles TG, Preiss NK, Shabaneh TB, Zhang P, Hawkes AR, Malik BT, Kolling FW, Usherwood EJ, Wong SL, Phillips JD, Shirai K, Angeles CV, Yan S, Curiel TJ, Huang YH, Cheng C, Turk MJ. Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma. Immunity. 2021; 54(9):2117-2132.
Vella JL, Molodtsov A, Angeles CV, Branchini BR, Turk MJ, Huang YH. Dendritic cells maintain anti-tumor immunity by positioning CD8 skin-resident memory T cells. Life Sci Alliance. 2021 Aug 6; 4(10):e202101056.
Han J, Zhao Y, Shirai K, Molodtsov A, Kolling FW, Fisher JL, Zhang P, Yan S, Searles TG, Bader JM, Gui J, Cheng C, Ernstoff MS, Turk MJ, Angeles CV. Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy. Nat Cancer. 2021 Mar;2(3):300-311.
Han J, Khatwani N, Searles TG, Turk MJ, Angeles CV. Memory CD8+ T cell responses to cancer. Semin Immunol. 2020 Jun; 49:101435.
Molodtsov AK, Lewis KA, Zhao Y, Vella JL, Khatwani N, Han J, Shabaneh TB, Zhang P, Hawkes AR, Malik BT, Kolling FW, Angeles CV, Yan S, Cheng C, Huang YH, Turk MJ. Resident Memory T Cells in Regional Lymph Nodes Sustain Immunity to Cancer. Immunity. Posted 18 Aug 2020
Khatwani N, Turk MJ. Oncogenes Feed Treg Cells without Calling CD8s to the Table. Immunity. 2020 Jul 14;53(1):13-15.
Sanseviero E, O'Brien EM, Karras JR, Shabaneh TB, Aksoy BA, Xu W, Zheng C, Yin X, Xu X, Karakousis GC, Amaravadi RK, Nam B, Turk MJ, Hammerbacher J, Rubinstein MP, Schuchter LM, Mitchell TC, Liu Q, Stone EL. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control. Cancer Immunol Res. 2019, 7(8):1371-1380.
Molodtsov A & Turk MJ. Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol. 2018, 29;9:2810
Zhao Y, Schaafsma E, Gorlov IP, Hernando E, Thomas NE, Shen R, Turk MJ, Berwick M, Amos CI, Cheng C. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Mol Cancer Res. 2019, 17(1):109-119.
Tamer B. Shabaneh, Aleksey K. Molodtsov, Shannon M. Steinberg, Peisheng Zhang, Gretel M. Torres, Gadisti A. Mohamed, Andrea Boni, Tyler J. Curiel, Christina V. Angeles, and Mary Jo Turk. Oncogenic BRAFV600E governs regulatory T cell recruitment during melanoma tumorigenesis. Cancer Res. 2018, 1;78(17):5038-5049
Lawrence F. Kuklinski, Shaofeng Yan, Zhongze Li, Jan L. Fisher, Chao Cheng, Randolph J. Noelle, Christina V. Angeles, Mary Jo Turk, Marc S. Ernstoff. VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival. Cancer Immunol Immunother. 2018 Jul;67(7):1113-1121.
Álvaro Padrón, Vincent Hurez, Harshita B.Gupta, Curtis A.Clark, Sri Lakshmi Pandeswara, Bin Yuan, Robert S. Svatek, Mary Jo Turk, Justin M. Drerup, Rong Li, Tyler J.Curiel. Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model. Exp Gerontol. 2018 May;105:146-154.
Marc S Ernstoff, Shipra Gandhi, Manu Pandey, Igor Puzanov, Petros Grivas, Alberto Montero, Vamsidhar Velcheti, Mary Jo Turk, Claudia Marcela Diaz-Montero, Lionel D Lewis, & Carl Morrison. Challenges faced when identifying patients for combination immunotherapy. Future Oncol. 2017 Aug;13(18):1607-1618.sciencedirect.com/…/pii/S0531556517307623
Brian T. Malik, Katelyn T. Byrne, Jennifer L. Vella, Peisheng Zhang, Tamer B. Shabaneh, Shannon M. Steinberg, Aleksey K. Molodtsov, Jacob S. Bowers, Christina V. Angeles, Chrystal M. Paulos, Yina H. Huang, and Mary Jo Turk. Resident memory T cells in skin mediate durable immunity to melanoma. Sci Immunol. 2017, 14;2(10)
Na Li, Wenwen Xu, Ying Yuan, Natarajan Ayithan, Yasutomo Imai, Xuesong Wu, Halli Miller, Michael Olson, Yunfeng Feng, Yina H. Huang, Mary Jo Turk, Samuel T. Hwang, Subramaniam Malarkannan, & Li Wang. Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis. Sci Rep. 2017, 3;7(1):1485
Shannon M. Steinberg, Tamer B. Shabaneh, Peisheng Zhang, Viktor Martyanov, Zhenghui Li, Brian T. Malik, Tamara A. Wood, Andrea Boni, Aleksey Molodtsov,Christina V. Angeles, Tyler J. Curiel, Michael L. Whitfield, and Mary Jo Turk. Myeloid cells that impair immunotherapy are restored in melanomas which acquire resistance to BRAF inhibitors. Cancer Res. 2017, 77(7): 1599–1610.
Curtis A. Clark, Harshita B. Gupta, Gangadhara Sareddy, Srilakshmi Pandeswara, Shunhua Lao, Bin Yuan, Justin M. Drerup, Alvaro Padron, José Conejo-Garcia, Kruthi Murthy, Yang Liu, Mary Jo Turk, Kathrin Thedieck, Vincent Hurez, Rong Li1, Ratna Vadlamudi, and Tyler J. Curiel. Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis and autophagy in ovarian cancer and melanoma. Cancer Res. 2016, 76(23): 6964–6974.
Eleanor Clancy-Thompson, Thomas J. Perekslis, Walburga Croteau, Matthew P. Alexander, Tamer B. Chabanet, Mary Jo Turk, Yina H. Huang, and David W. Mullins. Melanoma induces, and adenosine suppresses, CXCR3-cognate chemokine production and T-cell infiltration of lungs bearing metastatic-like disease. Cancer Immunol Res. 2015, 3(8): 956–967.
Shannon M. Steinberg and Mary Jo Turk. BRAF-inhibition and tumor immune suppression. Oncoimmunology. 2015, 4(2): e988039. Epub 2015 Mar 6.
Steinberg SM, Zhang P, Malik BT, Boni A, Shabaneh TB, Byrne KT, Mullins DW, Brinckerhoff CE, Ernstoff MS, Bosenberg MW, Turk MJ. BRAF inhibition alleviates immune suppression in murine autochthonous melanoma. Cancer Immunol Res. 2014, 2(11):1044-50. doi: 10.1158/2326-6066.CIR-14-0074. Epub 2014 Sep 2.
Toraya-Brown, Sheen MR, Zhang P, Chen L, Baird JR, Demidenko E, Turk MJ, Hoopes PJ, Conejo-Garcia JR, Fiering S1. Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. Nanomedicine. 2014,10(6):1273-1285. doi: 10.1016/j.nano.2014.01.011. Epub 2014 Feb 22.
Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, Mullins DW, Brinckerhoff CE. Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res. 2014, 27(3):495-501. doi: 10.1111/pcmr.12220. Epub 2014 Mar 6.
Byrne KT, Zhang P, Steinberg SM and MJ Turk. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. J Immunol. 2014, 192(4), 1433-9.
Byrne KT, Zhang P, Steinberg SM and MJ Turk. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. J Immunol. 2014, 192(4), 1433-9.
Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, Mullins DW, Brinckerhoff CE. Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res. 2014, 27(3), 495-501.
KT Byrne and MJ Turk. New perspectives on the role of vitiligo in immune responses to melanoma. Oncotarget 2011, 2(9), 684-94. Review Article.
KT Byrne, AL Côtè, P Zhang, SM Steinberg, Y Guo, SR Allie, W Zhang, MS Ernstoff , EJ Usherwood, and MJ Turk. Autoimmune melanocyte destruction is required for robust CD8 memory T cell responses to mouse melanoma. The Journal of Clinical Investigation 2011, 121(5): 1797-809.
AL Côtè, KT Byrne, SM Steinberg, P Zhang, and MJ Turk. Protective CD8 T cell memory to melanoma is generated in hosts lacking CD4 T cell help. PLoS One 2011, 6(10), e26491.
AL Côté, P Zhang, JA O’Sullivan, VL Jacobs, CR Clemis, S Sakaguchi, JA Guevara-Patiño, and MJ Turk. Stimulation of the glucocorticoid-induced TNFR family-related receptor (GITR) on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens. The Journal of Immunology 2011, 186; 1:275-83.
LW Collison, V Chaturvedi, AL Henderson, PR Giacomin, C Guy, J Bankoti, D Finkelstein, K Forbes, CJ Workman, SA Brown, JE Rehg, ML Jones, H Ni, D Artis, MJ Turk, and DAA Vignali. Interleukin-35-mediated induction of a novel regulatory T cell population. Nature Immunology 2010, 11; 12:1093-101.
W Zhang, T Zhang, MJ Turk, and EJ Usherwood. A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector. Cancer Immunology and Immunotherapy 2010, 59; 5:707-13.
KS Gunturu, KR Meehan, TA Mackenzie, TS Crocenzi, D McDermott, EJ Usherwood, KA Margolin, NA Crosby, MB Atkins, MJ Turk, C Ahonen, S Fuse, JI Clark, JL Fisher, RJ Noelle, and MS Ernstoff. Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery. Journal of Clinical Oncology 2010, 28; 7:1196-202.
Y Nesbeth, U Scarlett, J Cubillos-Ruiz, D Martinez, X Engle, MJ Turk, and JR Conejo-Garcia. CCL5-Mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Research 2009, 69; 15: 6331-8 (Cover Article).
E Huarte, J Fisher, MJ Turk, D Mellinger, C Foster, B Wolf, KR Meehan, CE Fadul, and MS Ernstoff. Ex vivo expansion of tumor-specific lymphocytes with IL-15 and IL-21 for adaptive immunotherapy. Cancer Letters 2009, 285; 1: 80-8.
AL Côtè, EJ Usherwood, and MJ Turk. Tumor-specific T cell memory: Clearing the regulatory T cell hurdle. Cancer Research 2008, 68; 6: 1614-7. Review Article.
CL Ahonen, A Wasiuk, S Fuse, MJ Turk, MS Ernstoff, AA Suriawinata, JD Gorham, RM Kedl, EJ Usherwood, and RJ Noelle. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared to unitary adjuvants as cancer vaccines. Blood 2008, 111; 6: 3116-25.
SP Bak, A Alonso, MJ Turk, and B Berwin. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. Mollecular Immunology 2008, 46; 2: 258-68.
PS Zhang, AL Côté, VC de Vries, EJ Usherwood, and MJ Turk. Induction of post-surgical tumor immunity and T cell memory by a poorly-immunogenic tumor. Cancer Research 2007, 67; 13 : 6468-76.
